Improving the Gene Ontology Resource to Facilitate More Informative Analysis and Interpretation of Alzheimer’s Disease Data
暂无分享,去创建一个
Helen Parkinson | Rina Bandopadhyay | Sandra Orchard | Ruth C Lovering | Birgit H M Meldal | Paola Roncaglia | Nigel M Hooper | Barbara Kramarz | David Brough | Maria J Martin | Rachael P Huntley | H. Parkinson | R. Huntley | M. Martin | R. Lovering | S. Orchard | D. Brough | N. Hooper | P. Roncaglia | B. Kramarz | B. Meldal | R. Bandopadhyay
[1] Kristel Sleegers,et al. Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics. , 2018, Trends in genetics : TIG.
[2] Bin Hu,et al. Ontology driven decision support for the diagnosis of mild cognitive impairment , 2014, Comput. Methods Programs Biomed..
[3] Henning Hermjakob,et al. The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..
[4] Marco Masseroli,et al. Analysis of metabolomic data: tools, current strategies and future challenges for omics data integration , 2016, Briefings Bioinform..
[5] Steven Mennerick,et al. Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.
[6] Sejal Patel,et al. Using Gene Ontology to describe the role of the neurexin-neuroligin-SHANK complex in human, mouse and rat and its relevance to autism , 2015, BMC Bioinformatics.
[7] D. Selkoe,et al. Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life , 2009, Neurobiology of Disease.
[8] David M Holtzman,et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.
[9] Weisong Liu,et al. The Rat Genome Database 2015: genomic, phenotypic and environmental variations and disease , 2014, Nucleic Acids Res..
[10] A. Draguhn,et al. Amyloid β Oligomers (Aβ1–42 Globulomer) Suppress Spontaneous Synaptic Activity by Inhibition of P/Q-Type Calcium Currents , 2008, The Journal of Neuroscience.
[11] M. Hagiwara,et al. Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly , 2015, Proceedings of the National Academy of Sciences.
[12] Henning Hermjakob,et al. The complex portal - an encyclopaedia of macromolecular complexes , 2014, Nucleic Acids Res..
[13] Guiquan Chen,et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease , 2000, Nature.
[14] Denise C. Park,et al. Beta-Amyloid Deposition and the Aging Brain , 2009, Neuropsychology Review.
[15] M. Mallar Chakravarty,et al. Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate Approach , 2016, Front. Neuroinform..
[16] Stijn van Dongen,et al. miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..
[17] Perry M. Elliott,et al. Improving Interpretation of Cardiac Phenotypes and Enhancing Discovery With Expanded Knowledge in the Gene Ontology , 2018, Circulation. Genomic and precision medicine.
[18] K. Yaffe,et al. The projected effect of risk factor reduction on Alzheimer's disease prevalence , 2011, The Lancet Neurology.
[19] Fleur Mougin,et al. Reuse of termino-ontological resources and text corpora for building a multilingual domain ontology: An application to Alzheimer's disease , 2014, J. Biomed. Informatics.
[20] B. Hyman,et al. Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions , 2013, Neurobiology of Disease.
[21] P. Cortelli,et al. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study. , 2018, Journal of Alzheimer's disease : JAD.
[22] Derek H. Oakley,et al. Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain , 2018, Front. Neurosci..
[23] Kimberly Van Auken,et al. A method for increasing expressivity of Gene Ontology annotations using a compositional approach , 2014, BMC Bioinformatics.
[24] Ira Milosevic. Revisiting the Role of Clathrin-Mediated Endoytosis in Synaptic Vesicle Recycling , 2018, Front. Cell. Neurosci..
[25] Hedi Peterson,et al. g:Profiler—a web server for functional interpretation of gene lists (2016 update) , 2016, Nucleic Acids Res..
[26] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[27] Daniele Pepe,et al. A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia , 2015, Neurobiology of Aging.
[28] E. Camon,et al. The Impact of Focused Gene Ontology Curation of Specific Mammalian Systems , 2011, PloS one.
[29] Rafael C. Jimenez,et al. The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases , 2013, Nucleic Acids Res..
[30] Alexander M. Phillips,et al. Regional protein expression in human Alzheimer’s brain correlates with disease severity , 2018, Communications Biology.
[31] J. Jia,et al. An Overview of Genome-Wide Association Studies in Alzheimer’s Disease , 2016, Neuroscience Bulletin.
[32] Tony Sawford,et al. Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease , 2016, Neuroinformatics.
[33] R. Malinow,et al. APP Processing and Synaptic Function , 2003, Neuron.
[34] Kimberly Van Auken,et al. A guide to best practices for Gene Ontology (GO) manual annotation , 2013, Database J. Biol. Databases Curation.
[35] Eric Karran,et al. The Cellular Phase of Alzheimer’s Disease , 2016, Cell.
[36] Maria C. Carrillo,et al. Common Alzheimer’s Disease Research Ontology: National Institute on Aging and Alzheimer’s Association Collaborative Project , 2012, Alzheimer's & Dementia.
[37] Tony Sawford,et al. Understanding how and why the Gene Ontology and its annotations evolve: the GO within UniProt , 2014, GigaScience.
[38] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[39] P. S. St George-Hyslop,et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. , 2000, Nature.
[40] The Gene Ontology Consortium. Expansion of the Gene Ontology knowledgebase and resources , 2016, Nucleic Acids Res..
[41] Christine Van Broeckhoven,et al. The genetic landscape of Alzheimer disease: clinical implications and perspectives , 2015, Genetics in Medicine.
[42] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[43] Minoru Kanehisa,et al. KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..
[44] P. Keller,et al. Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease , 2005 .
[45] Pascale Gaudet,et al. The Gene Ontology , 2019, Encyclopedia of Bioinformatics and Computational Biology.
[46] C. Dobson,et al. Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease , 2017, Proceedings of the National Academy of Sciences.
[47] Luc Buée,et al. What is the evidence that tau pathology spreads through prion-like propagation? , 2017, Acta neuropathologica communications.
[48] H. Braak,et al. Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue , 2017, Acta neuropathologica communications.
[49] Emily Perry,et al. The Ensembl Genome Browser: Strategies for Accessing Eukaryotic Genome Data. , 2018, Methods in molecular biology.
[50] A. Palmeri,et al. Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.
[51] Val Lowe,et al. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. , 2013, Brain : a journal of neurology.
[52] S. Younkin,et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[53] Elspeth A. Bruford,et al. Genenames.org: the HGNC resources in 2015 , 2014, Nucleic Acids Res..
[54] D. Forero,et al. Functional genomics of candidate genes derived from genome-wide association studies for five common neurological diseases , 2017, The International journal of neuroscience.
[55] Young Mok Park,et al. Proteogenomics of the human hippocampus: The road ahead. , 2015, Biochimica et biophysica acta.
[56] Rachael P. Huntley,et al. QuickGO: a web-based tool for Gene Ontology searching , 2009, Bioinform..
[57] Fei Liu,et al. Tau in Alzheimer disease and related tauopathies. , 2010, Current Alzheimer research.
[58] George A. Carlson,et al. The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[59] F. Kametani,et al. Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease , 2018, Front. Neurosci..
[60] M. Rattray,et al. Gene expression profiling in human neurodegenerative disease , 2012, Nature Reviews Neurology.
[61] Maria C. Carrillo,et al. International Alzheimer's Disease Research Portfolio (IADRP) aims to capture global Alzheimer's disease research funding , 2014, Alzheimer's & Dementia.
[62] A. Salminen,et al. Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases , 2014, Ageing Research Reviews.
[63] N. Hooper,et al. Amyloid-β Receptors: The Good, the Bad, and the Prion Protein* , 2015, The Journal of Biological Chemistry.
[64] J. Schott,et al. Inflammation in Alzheimer's disease: insights from immunotherapy. , 2013, Brain : a journal of neurology.
[65] D. Butterfield,et al. Amyloid β‐Peptide(1‐42) Contributes to the Oxidative Stress and Neurodegeneration Found in Alzheimer Disease Brain , 2004, Brain pathology.
[66] B. Zlokovic,et al. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. , 2016, Biochimica et biophysica acta.
[67] B. Hyman,et al. Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[69] Linda J. C. van Waalwijk van Doorn,et al. Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers. , 2018, Journal of Alzheimer's disease : JAD.
[70] Alex Bateman,et al. RNAcentral: a hub of information for non-coding RNA sequences , 2018, Nucleic Acids Res..
[71] Joanne L Welton,et al. Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis , 2017, Journal of extracellular vesicles.
[72] P. Keller,et al. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. , 2005, Journal of neurochemistry.
[73] M. Shelanski,et al. Neurogenic Effect of β-Amyloid Peptide in the Development of Neural Stem Cells , 2004, The Journal of Neuroscience.
[74] Hilla Peretz,et al. The , 1966 .
[75] Gang Fu,et al. Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data , 2014, Nucleic Acids Res..
[76] Henning Hermjakob,et al. Complex Portal 2018: extended content and enhanced visualization tools for macromolecular complexes , 2018, Nucleic Acids Res..
[77] Prudence Mutowo-Meullenet,et al. The GOA database: Gene Ontology annotation updates for 2015 , 2014, Nucleic Acids Res..
[78] Martin Hofmann-Apitius,et al. ADO: A disease ontology representing the domain knowledge specific to Alzheimer's disease , 2014, Alzheimer's & Dementia.
[79] S. Bicciato,et al. Regeneration of the entire human epidermis using transgenic stem cells , 2017, Nature.
[80] Perry G. Ridge,et al. Bridging the Gap between Statistical and Biological Epistasis in Alzheimer's Disease , 2015, BioMed research international.
[81] Wendy Noble,et al. Roles of tau protein in health and disease , 2017, Acta Neuropathologica.
[82] H. Braak,et al. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART , 2018, Acta Neuropathologica.
[83] Carol J. Bult,et al. Visual annotation display (VLAD): a tool for finding functional themes in lists of genes , 2015, Mammalian Genome.
[84] Kristel Sleegers,et al. Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond , 2016, The Lancet Neurology.
[85] Sangya Pundir,et al. UniProt Tools , 2016, Current protocols in bioinformatics.
[86] K. Imahori,et al. Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains* , 2009, The Journal of Biological Chemistry.
[87] The Gene Ontology Consortium,et al. Expansion of the Gene Ontology knowledgebase and resources , 2016, Nucleic Acids Res..
[88] R. Malenka,et al. Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms , 2008, Neuropsychopharmacology.
[89] Tatiana A. Tatusova,et al. Gene: a gene-centered information resource at NCBI , 2014, Nucleic Acids Res..
[90] Ruth C Lovering,et al. Exploring autophagy with Gene Ontology , 2016, Autophagy.
[91] Amaia M. Arranz,et al. Hallmarks of Alzheimer’s Disease in Stem-Cell-Derived Human Neurons Transplanted into Mouse Brain , 2017, Neuron.
[92] B. Hyman,et al. Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo , 2012, Nature Communications.
[93] J. Gallacher,et al. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing , 2018, bioRxiv.
[94] M. Shelanski,et al. Neurogenic effect of beta-amyloid peptide in the development of neural stem cells. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[95] Michelle K. Lupton,et al. ABCA7 p.G215S as potential protective factor for Alzheimer's disease , 2016, Neurobiology of Aging.
[96] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[97] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[98] Peter N. Robinson,et al. Clinical phenotype-based gene prioritization: an initial study using semantic similarity and the human phenotype ontology , 2014, BMC Bioinformatics.
[99] Shigeki Watanabe,et al. Synaptic Vesicle Endocytosis in Different Model Systems , 2018, Front. Cell. Neurosci..
[100] Chris Mungall,et al. AmiGO: online access to ontology and annotation data , 2008, Bioinform..
[101] Ralph A. Nixon,et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.
[102] J. Hardy,et al. The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.
[103] Rachael P. Huntley,et al. QuickGO: a user tutorial for the web-based Gene Ontology browser , 2009, Database J. Biol. Databases Curation.
[104] B. Barres,et al. Microglia and macrophages in brain homeostasis and disease , 2017, Nature Reviews Immunology.
[105] J. Hardy,et al. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.
[106] Giulia Antonazzo,et al. FlyBase 2.0: the next generation , 2018, Nucleic Acids Res..